Synergy Cancer Research Results

Synergy, Synergy: Click to Expand ⟱
Source:
Type:

Synergy — Interaction in which two or more agents, treatments, or biological interventions produce a combined effect greater than would be expected from their individual effects. In pharmacology and cancer research, synergy commonly refers to enhanced therapeutic efficacy when a compound is combined with chemotherapy, radiation, targeted therapy, or another bioactive agent.

Typical modulation in cancer: ↑ synergy is generally favorable when it increases tumor-cell killing, suppresses proliferation, enhances apoptosis or ferroptosis, or improves sensitivity to anticancer therapy. Synergy should be distinguished from simple additive effects and ideally supported by quantitative combination analysis such as combination index, Bliss independence, Loewe additivity, or related methods.

Typical modulation in Alzheimer’s disease: Context-dependent. Synergy may describe enhanced neuroprotective, anti-inflammatory, antioxidant, or cognitive effects produced by combinations of compounds or treatments, but it is not a disease-specific molecular pathway.



Scientific Papers found: Click to Expand⟱
7286- GGB,    Ginsenoside Rh2 shifts tumor metabolism from aerobic glycolysis to oxidative phosphorylation through regulating the HIF1-α/PDK4 axis in non-small cell lung cancer
- in-vitro, Lung, A549 - in-vitro, Lung, PC9
Hif1a↓, Glycolysis↓, OXPHOS↑, ROS↑, Apoptosis↑, toxicity↓, PDKs↓, HK2↓, LDHA↓, PFKFB2↓, PKM2↓, Synergy↑,
7260- Gink,    Ginkgetin: A natural biflavone with versatile pharmacological activities
- Review, Var, NA - Review, Stroke, NA - Review, AD, NA
*AntiCan↑, *Inflam↓, *AntiBio↑, *neuroP↑, *TumCCA↑, Apoptosis↑, TumAuto↑, iNOS↓, COX2/PTGS2↓, PGE2↓, NF-kB↓, PLA2↓, *neuroP↑, *Stroke↓, *AntiFungal↓, *Bacteria↓, Bcl-xL↓, Bcl-2↓, Casp9↑, Casp3↑, cl‑PARP↑, IL6↓, STAT3↓, JAK1↓, survivin↓, COX2/PTGS2↓, IAP1↓, MMP2↓, MMP9↓, PTEN↑, SHP1↑, Synergy↑, TumVol↓, TumW↓, *toxicity↓, *ROS↓,
7265- Gink,    Ginkgetin targets GRP78 to induce dual pathways of ER stress and immune activation in osteosarcoma
- vitro+vivo, OS, NA
GRP78/BiP↓, TumCP↓, TumCMig↓, TumCI↓, Apoptosis↑, TumAuto↑, PERK↑, eIF2α↑, ATF4↑, TumCG↓, TumMeta↓, Synergy↑,
7306- GoldNP,  Rad,    Gold nanoparticles enhance the radiation therapy of a murine squamous cell carcinoma
- in-vivo, SCC, NA
Synergy↑, RadioS↑,
7320- Gos,    AT-101 Enhances the Antitumor Activity of Lenalidomide in Patients with Multiple Myeloma
- Trial, Melanoma, NA
Bcl-2↓, Mcl-1↓, Apoptosis↑, Synergy↑, toxicity↝, ORR↑,
7311- Gos,    Systematic Review of Gossypol/AT-101 in Cancer Clinical Trials
- Review, CLL, NA
Dose↝, toxicity↓, PFS↓, OS↑, Synergy↑, BioAv↑, Bcl-2↓, ROS↑, MOMP↑, Dose↑, Casp3↑, Casp9↑, MMP↑, VEGF↓, APE1/APEX1↓, ChemoSen↑, RadioS↑, toxicity↑, AST↑, ALAT↑,
7482- H2,    Molecular Hydrogen Therapy: Mechanisms, Delivery Methods, Preventive, and Therapeutic Application
- Review, Var, NA - Review, IBD, NA - Review, Stroke, NA - Review, Sepsis, NA - Review, AD, NA
Dose↝, *Inflam↓, *IL1β↓, *IL6↓, *TNF-α↓, *neuroP↑, *mTOR↓, *IL10↑, *TGF-β↑, *Sepsis↓, *NRF2↑, *antiOx↑, *Catalase↑, *SOD↑, *GPx↑, *ROS↓, *HO-1↑, *PI3K↑, *Akt↑, *hepatoP↑, *MPO↓, *cardioP↑, CDK4↓, CDK6↑, CD47↓, PI3K↓, Akt↓, Hif1a↓, selectivity↑, *MMP↑, *ATP↑, *ER Stress↓, *CHOP/DDIT3↓, *Casp12↓, *GRP78/BiP↓, *p38↓, *p‑JNK↓, *LC3‑Ⅱ/LC3‑Ⅰ↑, *p‑eIF2α↓, *ATF4↓, *XBP-1↓, *Imm↑, *IFN-γ↓, *IL4↓, *GranB/GZMB↓, NK cell↑, radioP↑, *CD4+↑, CD8+↑, *Dose↝, *other↑, *Dose↝, *antiPs↑, *BioAv↝, *GutMicro↑, Dose↝, *IBI↑, TumCP↓, TumCI↓, TumCMig↓, CD8+↑, PGC-1α↑, Akt↓, SCD1↓, *MDA↓, Synergy↑, *APP↓, *BACE/β-secretase↓, *Aβ↓, *cognitive↑, *neuroP↑, NP/CIPN↓, *Stroke↓, *NLRP3↓, *ALAT↓, *AST↓, *LPS↓, *hepatoP↑, chemoP↑, *creat↓, *Urea↓, *RenoP↑, *eff↑, Apoptosis↑, XIAP↓, IAP2/BIRC3↓, TumVol↓, MALAT1↓, EZH2↓, miR-124-3p↓, eff↑, ChemoSen↑, *compII↑, *compIII↑, *LDL↓, *Obesity↓, QoL↑, PFS↑, *antiAll↑,
2516- H2,    Hydrogen Gas in Cancer Treatment
- Review, Var, NA
*Half-Life↓, *ROS↓, *selectivity↑, *SOD↑, *HO-1↑, *NRF2↑, *chemoP↑, *radioP↑, ROS↑, *Inflam↓, eff↑, *TNF-α↓, *IL6↓, *cl‑Casp8↑, *Bax:Bcl2↓, *Apoptosis↓, *cardioP↑, *hepatoP↑, *RenoP↑, *chemoP↑, eff↝, chemoP↑, radioP↑, Synergy↑, TumCG↓, Ki-67↓, VEGF↓, selectivity↑,
2528- H2,    Local generation of hydrogen for enhanced photothermal therapy
- in-vitro, Var, NA
Synergy↑, ROS↓, selectivity↑, ROS↑, other↝, ROS↑,
3152- H2,  VitC,  Rad,    Hydrogen and Vitamin C Combination Therapy: A Novel Method of Radioprotection
- in-vitro, Nor, HUVECs - in-vivo, NA, NA
AntiTum↑, OS↑, QoL↑, TumVol↓, radioP↑, Dose↑, Dose↝, Synergy↑,
1627- HCA,  CRMs,  Sper,    Caloric Restriction Mimetics Enhance Anticancer Immunosurveillance
- Review, Var, NA
ChemoSen↑, Synergy↑, ACLY↓, LC3‑Ⅱ/LC3‑Ⅰ↑, TumAuto↑, other↓,
1628- HCA,  ALA,    Addition of Hydroxy Citrate improves effect of ALA
- Review, Var, NA
ACLY↓, other↓, ROS↑, Synergy↑, PDKs↓,
7455- HNK,    Honokiol in cancer: Roles in enhancing combination therapy efficacy and preventing post-transplant malignancies
- Review, Var, NA
ChemoSen↑, Imm↝, *hepatoP↑, *cardioP↑, *neuroP↑, *AntiCan↑, *Inflam↓, *antiOx↑, Synergy↑, *TNF-α↓, *IL1?, *IL6?,
2865- HNK,    Liposomal Honokiol induces ROS-mediated apoptosis via regulation of ERK/p38-MAPK signaling and autophagic inhibition in human medulloblastoma
- in-vitro, MB, DAOY - vitro+vivo, NA, NA
BioAv↓, BioAv↓, TumCP↓, selectivity↑, P53↑, P21↑, CDK4↓, cycD1/CCND1↓, mtDam↑, ROS↑, eff↓, Casp3↑, BAX↑, LC3II↑, Beclin-1/ATG6↑, ATG7↑, p62↑, Synergy↑, ChemoSen↑, *toxicity↓,
2864- HNK,    Honokiol: A Review of Its Anticancer Potential and Mechanisms
- Review, Var, NA
TumCCA↑, CDK2↓, EMT↓, MMPs↓, AMPK↑, TumCI↓, TumCMig↓, TumMeta↓, VEGFR2/KDR/Flk1↓, *antiOx↑, *Inflam↓, *BBB↑, *neuroP↑, *ROS↓, Dose↝, selectivity↑, Casp3↑, Casp9↑, NOTCH1↓, cycD1/CCND1↓, cMyc↓, P21?, DR5↑, cl‑PARP↑, P53↑, Mcl-1↑, p65↓, NF-kB↓, ROS↑, JNK↑, NRF2↑, cJun↑, EF-1α↓, MAPK↓, PI3K↓, mTORC1↓, CSCs↓, OCT4↓, Nanog↓, SOX4↓, STAT3↓, CDK4↓, p‑RB1↓, PGE2↓, COX2/PTGS2↓, β-catenin/ZEB1↑, IKKα↓, HDAC↓, HATs↑, H3↑, H4↑, LC3II↑, c-Raf↓, SIRT3↑, Hif1a↓, ER Stress↑, GRP78/BiP↑, cl‑CHOP/DDIT3↑, MMP↓, PCNA↓, Zeb1↓, NOTCH3↓, CD133↓, Nestin↓, ATG5↑, ATG7↑, survivin↓, ChemoSen↑, SOX2↓, OS↑, P-gp/ABCB1↓, Half-Life↓, Half-Life↝, Synergy↑, BioAv↓,
7574- HPT,  Oxy,    Improvement of tumor oxygenation by mild hyperthermia
- Review, Var, NA
Hypoxia↓, OCR↓, RadioS↑, Synergy↑, Dose↝,
5051- HPT,  doxoR,    Hyperthermia Enhances Doxorubicin Therapeutic Efficacy against A375 and MNT-1 Melanoma Cells
- in-vitro, Melanoma, A375
tumCV↓, TumCCA↑, ROS↑, Synergy↑,
7643- Ins,  IP6,    Efficacy of IP6 + inositol in the treatment of breast cancer patients receiving chemotherapy: prospective, randomized, pilot clinical stud
- Trial, BC, NA
RBC↑, QoL↑, Synergy↑, Imm↑, ChemoSen↑, chemoP↑, Dose↝,
7636- Ins,    Myo-Inositol: Pharmacokinetics, Biological Functions, and Therapeutic Potential in Liver Protection: Insights from Preclinical Models
- Review, Nor, NA
*glucose↝, *lipid-P↓, *ROS↓, *BioAv↑, *hepatoP↑, *Inflam↓, *MMP↑, *ATP↑, *GutMicro↑, *Dose↝, *Half-Life↝, *BioAv↑, *Synergy↑, *hepatoP↑, *SOD↑, *Catalase↑, *Casp3↓, *ALAT↓, *AST↓, *AMPK↑, *SREBP1/SREBF1↑, NA↑,
7635- Ins,    The Role of Inositols in Endocrine and Neuroendocrine Tumors
- Review, Thyroid, NA
*Dose↝, VEGF↓, Imm↑, NK cell↑, Synergy↑, PI3K↓, Akt↓, EMT↓, MAPK↓, Wnt↓, NF-kB↓, IRes↓, *ROS↓, TumVol↓, *TSHR↓,
7631- Ins,  IP6,    Broad Spectrum Anticancer Activity of Myo-Inositol and Inositol Hexakisphosphate
- Review, Var, NA
other↑, p‑pRB↓, TumCCA↑, PI3K↓, Akt↓, ERK↓, NF-kB↓, COX2/PTGS2↓, PGE2↓, PSEN1/PS1↓, EMT↓, Wnt↓, β-catenin/ZEB1↓, NOTCH1↓, N-cadherin↓, Snail↓, E-cadherin↑, fascin↓, Cofilin↓, MMPs↓, ROCK1↓, Dose↝, other↝, selectivity↑, *ROS↓, *lipid-P↓, ROS↑, NK cell↑, Imm↑, TNF-α↓, ChemoSen↑, Dose↑, toxicity↓, QoL↑, chemoP↑, OS↑, Dose↝, Insulin↓, glucose↝, lipoGen↓, Synergy↑,
7672- iod,    Adjuvant Effect of Molecular Iodine in Conventional Chemotherapy for Breast Cancer. Randomized Pilot Study
- Trial, BC, NA
Dose↝, OS↑, TumCI↓, Apoptosis↑, EstroRS/ERS↑, Synergy↑, *cardioP↑, *antiOx↑, *Inflam↓,
7653- IP,    Generation of systemic antitumour immunity via the in situ modulation of the gut microbiome by an orally administered inulin gel
- in-vivo, Var, NA
GutMicro↑, T-Cell↑, AntiTum↑, Synergy↑, TumCG↓,
7722- IP6,    Cancer inhibition by inositol hexaphosphate (IP6) and inositol: from laboratory to clinic
- Review, Var, NA
Synergy↑, TumCP↓, Diff↑, TumCCA↑, Imm↑, antiOx↑, BioAv↑, toxicity↓, ChemoSen↑, TumMeta↓, QoL↑,
7690- IP6,  Ins,    Inositol Hexaphosphate (IP6) and Colon Cancer: From Concepts and First Experiments to Clinical Application
- Review, Colon, NA
AntiCan↑, Imm↑, antiOx↑, TumCP↓, Diff↑, TumCG↓, Synergy↑, P21↓, p27/CDKN1B↓, pRB↓, TumCCA↑, PI3K↓, Akt↓, PKCδ↓, RAS↓, ERK↓, NF-kB↓, Inflam↓, MMP9↓, IronCh↑, NK cell↑, selectivity↑, ChemoSen↑, chemoP↑, toxicity↓, Remission↑,
7696- IP6,  Ins,    The Combination of Inositol Hexaphosphate and Inositol Inhibits Metastasis of Colorectal Cancer Cells by Upregulating Claudin 7
- vitro+vivo, Colon, SW48 - in-vitro, Colon, SW-620
AntiCan↑, CLDN7↑, EMT↓, E-cadherin↑, N-cadherin↓, Synergy↑, TumCG↓,
9247- ISO, IH,  capec,    Isorhamnetin augments the anti-tumor effect of capecitabine through the negative regulation of NF-κB signaling cascade in gastric cancer
- vitro+vivo, GC, NA
tumCV↓, Synergy↑, NF-kB↓, TumCG↑,
7861- isoO,    Isoorientin Inhibits Inflammation in Macrophages and Endotoxemia Mice by Regulating Glycogen Synthase Kinase 3 β
- vitro+vivo, Nor, RAW264.7
*Inflam↓, *GSK‐3β↓, *TNF-α↓, *IL6↓, *IL1β↓, *p‑GSK‐3β↑, *Synergy↑, *COX2/PTGS2↓, *ERK↓, *NF-kB↓, *NRF2↑, *HO-1↑, *OCLN↑, *ZO-1↑, *BBB↝,
7835- ISQ,  QC,    Synergistic Protection by Isoquercitrin and Quercetin against Glutamate-Induced Oxidative Cell Death in HT22 Cells via Activating Nrf2 and HO-1 Signaling Pathway: Neuroprotective Principles and Mechanisms of Dendropanax morbifera Leaves
- in-vitro, AD, HT22
*Apoptosis↓, *ROS↓, *SOD2↑, *Ca+2↓, *mtDam↓, *NRF2↑, *HO-1↑, *other↑, *AIF↓, *LC3‑Ⅱ/LC3‑Ⅰ↓, *Synergy↑,
9173- ITCs,  SFN,    Dietary isothiocyanates and anticancer agents: exploring synergism for improved cancer management
- Review, Var, NA
Synergy↑, AntiCan↑, chemoP↑, ChemoSen?, toxicity↓, ROS↑, NRF2↑, NF-kB↓, CYP1A1↓, CYP1A2↓, CYP1B1↓, TumCCA↑, PI3K↓, Akt↓, mTOR↓, PTEN↑, BAX↑, ChemoSen↑, Synergy↑, Synergy↑, Synergy↑, Synergy↑, Synergy↑, Dose↝, Synergy↑,
9191- ITCs,  AITC,  BITC,  PEITC,  SFN  Molecular Targets of Isothiocyanates in Cancer: Recent Advances
- Review, Var, NA
Risk↓, TumCG↓, ROS↑, TumCCA↑, Apoptosis↑, Ingr?, chemoPv↑, P450↓, SXR↓, CYP3A4↓, NRF2↑, ARE↑, HO-1↑, p38↓, TrxR↑, Trx↑, NF-kB↓, AP-1↓, BioAv↑, Akt↓, STAT3↓, HDAC↓, VEGF↓, MMP2↓, Hif1a↓, CD31/PECAM-1↓, PI3K↓, PDK1 / PDPK1↓, mTOR↓, FOXO1↓, FOXO3↓, BIM↑, p27/CDKN1B↑, P21↑, HER2/EBBR2↓, EGFR↓, Bcl-xL↓, XIAP↓, ROS↓, Zeb1↓, Snail↓, E-cadherin↑, MMP2↓, MMP9↓, ROS↑, MMP↓, Casp↑, DNAdam↑, TumCCA↑, γH2AX↑, CSCs↓, OCT4↓, SOX2↓, Nanog↓, NOTCH2↑, selectivity↝, ETC↓, compI↓, compIII↓, OCR↓, Synergy↑, ChemoSen↑, RadioS↑, Synergy↑, Synergy↑, Synergy↑, Synergy↑, Synergy↑,
9193- ITCs,  PEITC,  BITC,  SFN,    Cancer chemoprevention with dietary isothiocyanates mature for clinical translational research
- Review, Var, NA
Risk↓, TumCCA↑, TumCD↑, selectivity↑, TumCP↓, angioG↓, EMT↓, CSCs↓, NF-kB↓, NOTCH↑, BioAv↑, AntiCan↑, Synergy↑, Polyps↓, ROS↑, compIII↓, ChemoSen↑, RadioS↑, *p‑4E-BP1↓,
7994- itraC,    From fungus fighter to cancer slayer: itraconazole as a multifaceted candidate for drug-resistant prostate cancer
- Review, Pca, NA
HH↓, Gli1↓, TumCP↓, TumCI↓, Synergy↑,
8033- IVM,  dietMet,  rMETase,    Direct comparison of efficacy of combining ivermectin versus five first-line chemotherapy drugs with recombinant methioninase against colon-cancer cells
- in-vitro, CRC, HCT116
eff↑, ChemoSen↑, Synergy↑, selectivity↑, Synergy↑, TumCCA↑,
8029- IVM,    Ivermectin in Cancer Treatment: Should Healthcare Providers Caution or Explore Its Therapeutic Potential?
- Review, Var, NA
TumCP↓, Apoptosis↑, Wnt↓, β-catenin/ZEB1↓, Akt↓, mTOR↓, BBB∅, ROS↑, MMP↓, Casp3↓, Casp9↑, TumCCA↑, P53↑, cMyc↓, MMP9↓, HSP27↓, ICD↑, Synergy↑, *AntiP↑,
8026- IVM,  immuno,    Ivermectin converts cold tumors hot and synergizes with immune checkpoint blockade for treatment of breast cancer
- vitro+vivo, BC, 4T1
ICD↑, Imm↝, Synergy↑, TumVol↓,
8006- JG,  VitC,    Juglone-ascorbate treatment enhances reactive oxygen species mediated mitochondrial apoptosis in pancreatic cancer
- in-vitro, PC, PANC1 - in-vitro, PC, Bxpc-3
TumCP↓, ROS↑, antiOx⇅, Bcl-2↓, survivin↓, BAX↑, Trx2↓, Synergy↑,
7962- JG,    Peptidyl prolyl isomerase, Pin1 is a potential target for enhancing the therapeutic efficacy of etoposide
- in-vitro, Var, NA
Synergy↑, Pin1↓, *DNAdam↓,
5115- JG,    Natural Products to Fight Cancer: A Focus on Juglans regia
- Review, Var, NA
Casp3↑, Casp9↑, MMP↓, AR↓, PSA↓, E-cadherin↑, N-cadherin↓, Vim↓, Akt↓, GSK‐3β↓, EMT↑, TumCI↓, MMP9↓, VEGF↓, MMP2↓, TumCCA↑, ROS↑, Apoptosis↑, GSH↓, Catalase↓, SOD↓, GPx↓, DNAdam↑, γH2AX↑, Synergy↑, BAX↑, Fas↑, Pin1↓,
8068- KAE,  TRAIL/rTRAIL,    Kaempferol sensitizes colon cancer cells to TRAIL-induced apoptosis
- in-vitro, Colon, NA
Synergy↑, DR4↑, DR5↑,
8072- KAE,    Natural defense against colorectal cancer: the effects of kaempferol on epigenetics, apoptosis, inflammation, oxidative stress, and cell proliferation
- Review, CRC, NA
AntiCan↑, TumCP↓, TumCI↓, Inflam↓, angioG↓, ROS↑, Apoptosis↑, ChemoSen↑, Risk↓, *antiOx↑, *Inflam↓, *AntiBio↑, *cardioP↑, *neuroP↑, selectivity↑, PUMA↑, Cyt‑c↑, cl‑Casp3↑, cl‑PARP↑, Apoptosis↑, NF-kB↓, COX2/PTGS2↓, CC(CDKs/cyclins)↓, TumCCA↑, BioAv↓, Synergy↑, DR4↑, DR5↑, Casp3↑, Casp9↑, Casp7↑, TumCP↓, TumCI↓, TumAuto↑, mtDam↑, P53↑, MAPK↑, *lipid-P↓, *TAC↑, *Catalase↑, *SOD↑, *GPx↑, *NRF2↑,
8055- KAE,    Molecular Mechanisms of the Anticancer Activity of the Flavonoid Kaempferol: A Comprehensive Review
- Review, Var, NA
antiNeop↑, *toxicity↓, TumCCA↑, ROS↑, ER Stress↑, TumAuto↑, Pyro↑, Ferroptosis↑, angioG↓, Imm↝, Synergy↑, ChemoSen↑, MPT↑, MMP↓, mtDam↑, Cyt‑c↑, Bax:Bcl2↑, Fas↑, DR4↑, DR5↑, JNK↑, ERK↑, CHOP/DDIT3↑, ER Stress↑, UPR↑, Ca+2↑, PI3K↓, Akt↓, mTOR↓, AMPK↑, *Ferroptosis↓, *antiOx↑, *NRF2↑, *GPx4↑, *ROS↓, *MDA↓, *i-Iron↓, *xCT/SLC7A11↑, VEGF↓, Wnt↓, β-catenin/ZEB1↓, EMT↓, STAT3↓, M2 MC↓, MCP1/CCL2↓, MMP9↓, MMP2↓, TIMP2↓, ChemoSen↑, PKM2↑, Glycolysis↓, CSCs↓, SOX4↓, OCT4↓, CD44↓, Nanog↓, MDR1↓, *GutMicro↑,
9002- L-THE,    Effects of theanine on growth of human lung cancer and leukemia cells as well as migration and invasion of human lung cancer cells
- in-vitro, Lung, A549 - in-vitro, AML, K562
tumCV↓, Synergy↑, TumCMig↓, TumCI↓, Dose↝,
8156- lamb,    A review on chemistry, source and therapeutic potential of lambertianic acid
- Review, Var, NA
*Obesity↓, *AntiCan↑, *AMPK↑, *β-HEX↓, NA↑, TumCCA↑, AMPK↑, ACC↑, p‑Akt↓, FOXM1↓, CycB/CCNB1↓, XIAP↓, Bcl-2↓, p‑STAT3↓, p‑NF-kB↓, Bcl-xL↓, survivin↓, VEGF↓, COX2/PTGS2↓, cMyc↓, IL6↓, TNF-α↓, ROS↑, STK11/LKB1↑, cl‑Casp3↑, cl‑PARP↑, Synergy↑, AR↓, TumCP↓, p‑P53↓, P21↓, p27/CDKN1B↓, cycD1/CCND1↓, CDK4↓, PSA↓, STAT3↓, ac‑p65↓, *antiAll↑,
8174- Lap,    Lapatinib: a dual inhibitor of human epidermal growth factor receptor tyrosine kinases
- in-vitro, Var, NA
EGFR↓, HER2/EBBR2↓, BioAv↝, Synergy↑, Dose↝,
8341- LDN,    Low-Dose Naltrexone as an Adjuvant in Combined Anticancer Therapy
- Review, Var, NA
OGFr↑, TumCP↓, TumCCA↑, Apoptosis↑, toxicity↝, Half-Life↝, *FasL↓, *Fas↓, BAX↑, Casp9↑, Casp3↑, Bcl-2↓, survivin↓, PI3K↓, PDK1 / PDPK1↓, mTOR↓, ChemoSen↑, chemoP↑, Synergy↑, QoL∅,
8277- LE,    Oncopreventive and oncotherapeutic potential of licorice triterpenoid compound glycyrrhizin and its derivatives: Molecular insights
- Review, Var, NA
*antiOx↑, *AntiTum↑, HMGB1↓, COX2/PTGS2↓, PGE2↓, TumCP↓, TumCCA↑, Synergy↑, MMP↓, p‑P53↑, BAX↑, cl‑PARP↑, proCasp3↑, proCasp8↑, proCasp9↑, ROS↑, TumAuto↑, MMP9↓, TumMeta↓, PI3K↓, Akt↓, eff↑, *chemoP↑, *NRF2↑, *NF-kB↓,
1790- LEC,  DHA,    Dietary Crude Lecithin Increases Systemic Availability of Dietary Docosahexaenoic Acid with Combined Intake in Rats
- in-vivo, Nor, NA
*Synergy↑, other↑,
1795- LEC,  Chit,    Self-assembled lecithin-chitosan nanoparticles improve the oral bioavailability and alter the pharmacokinetics of raloxifene
- in-vivo, Nor, NA
Synergy↑, BioAv↑,
6464- LIN,  1,8-Cin,    Anti-cancer mechanisms of linalool and 1,8-cineole in non-small cell lung cancer A549 cells
- in-vitro, NSCLC, A549 - in-vitro, Nor, WI38
TumCP↓, TumCCA↑, selectivity↑, ROS↑, MMP↓, eff↓, TumCMig↓, Synergy↑,

Showing Research Papers: 251 to 300 of 499
Prev Page 6 of 10 Next

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 499

Pathway results for Effect on Cancer / Diseased Cells:


NA, unassigned(tgid=0) ⓘ

NA↑, 4,  

Redox & Oxidative Stress(tgid=1) ⓘ

antiOx?, 1,   antiOx↓, 1,   antiOx↑, 8,   antiOx⇅, 1,   ARE↑, 1,   Catalase↓, 4,   Catalase↑, 3,   Fenton↑, 5,   frataxin↑, 1,   GPx↓, 3,   GPx↑, 3,   GPx4↓, 5,   GPx4↑, 1,   GSH↓, 23,   GSH↑, 1,   GSH↝, 1,   GSR↑, 1,   GSSG↑, 1,   GSTs↓, 1,   H2O2↑, 6,   HO-1↓, 3,   HO-1↑, 11,   hyperG↓, 1,   Iron↑, 5,   i-Iron↑, 2,   Keap1↑, 1,   lipid-P?, 1,   lipid-P↓, 3,   lipid-P↑, 11,   MDA↓, 2,   MDA↑, 5,   NQO1↑, 3,   NRF2↓, 11,   NRF2↑, 15,   PrxI↓, 1,   PYCR1↓, 1,   RNS↑, 1,   ROS?, 2,   ROS↓, 24,   ROS↑, 197,   ROS⇅, 4,   i-ROS↑, 2,   mt-ROS↑, 3,   SOD↓, 6,   SOD↑, 3,   TAC↓, 1,   Trx↓, 3,   Trx↑, 2,   Trx1↓, 1,   Trx2↓, 1,   TrxR↓, 4,   TrxR↑, 2,   TrxR1?, 1,   TrxR1↓, 1,   xCT/SLC7A11↓, 5,   xCT/SLC7A11↑, 1,  

Metal & Cofactor Biology(tgid=2) ⓘ

Ferritin↓, 2,   IronCh↑, 1,   Mets↑, 1,   Tf↓, 1,  

Mitochondria & Bioenergetics(tgid=3) ⓘ

ADP:ATP↑, 1,   BCR-ABL↓, 1,   CDC2↓, 3,   CDC25↓, 2,   compI↓, 4,   compIII↓, 4,   compV↓, 1,   EGF↓, 2,   ETC↓, 2,   ETC↑, 1,   ETC↝, 1,   Insulin↓, 2,   MFN2↑, 1,   mitResp↓, 2,   mitResp↑, 3,   Mortalin↓, 1,   mtDam↑, 14,   OCR↓, 3,   OCR↑, 3,   OXPHOS↓, 9,   OXPHOS↑, 7,   OXPHOS↝, 2,   PDH↓, 1,   PDH↑, 5,   p‑PDH↑, 1,   PGC-1α↑, 1,   PINK1↑, 1,   SDH↓, 1,   SIRT3↓, 1,   SIRT3↑, 2,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

5LO↓, 5,   ACC↑, 3,   ACLY↓, 4,   p‑ACLY↓, 1,   ACSL4↑, 2,   adiP↑, 1,   Alanine↓, 1,   ALAT↓, 4,   ALAT↑, 1,   AMP↑, 1,   AMPK↑, 18,   ATP↓, 14,   ATP↑, 2,   mt-ATP↓, 1,   CAIX/CA9↓, 1,   CAIX/CA9↑, 1,   citrate↓, 2,   CPT1A↓, 1,   ECAR↓, 1,   FASN↓, 4,   FASN↑, 1,   GAPDH↓, 1,   glucoNG↓, 1,   glucose↓, 1,   glucose↝, 1,   GlucoseCon↓, 7,   GlucoseCon↑, 1,   GlutMet↓, 1,   glyC↓, 1,   Glycine↓, 1,   Glycolysis↓, 41,   Glycolysis↑, 1,   Glycolysis↝, 1,   GSK‐3β↓, 4,   GSK‐3β↑, 3,   p‑GSK‐3β↓, 2,   p‑GSK‐3β↑, 1,   Histones↝, 1,   HK1↓, 1,   HK2↓, 18,   HMG-CoA↓, 9,   KeyT↑, 1,   lactateProd↓, 12,   lactateProd↑, 1,   LDHA↓, 7,   LDL↓, 3,   lipoGen↓, 2,   MCT4↓, 1,   NAD↓, 1,   NADH:NAD↓, 1,   NADPH↓, 4,   NADPH↑, 2,   PDHB↓, 1,   PDK1 / PDPK1↓, 9,   PDK3↑, 1,   PDKs↓, 10,   PFK↓, 2,   PFK1↓, 1,   PFK2?, 1,   PKM2↓, 12,   PKM2↑, 1,   PLA2↓, 1,   Pyruv↓, 1,   SCD1↓, 1,   SIRT1↓, 3,   SIRT1↑, 4,   SIRT2↓, 2,   SREBP2↓, 2,   TCA↓, 3,   TCA↑, 2,   TS↓, 1,   Warburg↓, 13,   β-oxidation↓, 1,  

Cell Death(tgid=5) ⓘ

AIF↑, 3,   APAF1↑, 2,   Apoptosis?, 2,   Apoptosis↓, 4,   Apoptosis↑, 142,   ASK1↑, 1,   BAD↑, 4,   BAD↝, 1,   Bak↑, 5,   BAX↓, 3,   BAX↑, 68,   BAX↝, 2,   Bax:Bcl2↑, 20,   Bcl-2↓, 75,   Bcl-2↑, 2,   Bcl-2↝, 1,   Bcl-xL↓, 17,   Bcl-xL↑, 1,   BID↑, 1,   BIM↑, 7,   BNIP3↑, 1,   Casp↑, 23,   Casp1↑, 1,   Casp12?, 1,   Casp12↑, 1,   Casp2↑, 1,   Casp3↓, 3,   Casp3↑, 83,   cl‑Casp3↑, 14,   cl‑Casp3⇅, 1,   proCasp3↑, 2,   pro‑Casp3↑, 1,   Casp7↑, 7,   cl‑Casp7↑, 3,   Casp8↓, 1,   Casp8↑, 8,   cl‑Casp8↑, 2,   proCasp8↑, 2,   pro‑Casp8↑, 1,   Casp9↓, 1,   Casp9↑, 45,   cl‑Casp9↑, 6,   proCasp9↑, 2,   CellShr↑, 2,   cFLIP↓, 2,   Cupro↑, 1,   Cyt‑c↑, 45,   Diablo↑, 4,   DR5↑, 14,   FADD↑, 3,   Fas?, 1,   Fas↑, 10,   FasL↑, 2,   Ferroptosis↓, 1,   Ferroptosis↑, 15,   GSDME-N↑, 1,   HEY1↓, 1,   IAP1↓, 4,   IAP2/BIRC3↓, 1,   cl‑IAP2/BIRC3↑, 1,   ICD↑, 2,   iNOS↓, 7,   iNOS↑, 2,   Mcl-1↓, 17,   Mcl-1↑, 1,   MDM2↓, 3,   MDM2↑, 1,   MLKL↑, 1,   p‑MLKL↓, 1,   MOMP↑, 3,   Necroptosis↑, 3,   necrosis↑, 2,   NOXA↑, 1,   p38↓, 3,   p38↑, 6,   p‑p38↓, 1,   p‑p38↑, 2,   Paraptosis↑, 2,   PUMA↑, 3,   Pyro↑, 4,   RIP3↑, 1,   p‑RIP3↑, 1,   survivin↓, 27,   TNFR 1↑, 1,   TRAIL↑, 1,   TumCD↓, 2,   TumCD↑, 22,   XIAP↓, 15,   YAP/TEAD↓, 1,  

Kinase & Signal Transduction(tgid=6) ⓘ

Akt?, 1,   Akt↓, 77,   Akt↑, 11,   p‑Akt↓, 19,   Akt2↓, 1,   AMPKα↑, 1,   BRAF↓, 1,   CK2↓, 4,   cSrc↓, 1,   DYRK1B↓, 1,   EF-1α↓, 1,   EGFR↓, 23,   ERK↓, 15,   ERK↑, 6,   ERK↝, 1,   p‑ERK↓, 11,   FGFR1↓, 1,   FOXD3↑, 1,   HCAR2↑, 1,   HER2/EBBR2↓, 9,   HGF/c-Met↓, 1,   IGF-1R↓, 4,   IGF-1R↑, 1,   IKKα↓, 3,   IκB↓, 1,   IκB↑, 1,   JAK↓, 3,   JAK1↓, 2,   JAK2↓, 8,   JAK3↓, 1,   JNK↓, 3,   JNK↑, 11,   p‑JNK↓, 3,   p‑JNK↑, 1,   p‑MAP2K1/MEK1↓, 1,   MAPK↓, 11,   MAPK↑, 7,   MAPK↝, 1,   p‑MAPK↓, 1,   MEK↓, 6,   mTOR↓, 49,   mTOR↑, 2,   mTOR↝, 1,   p‑mTOR↓, 4,   mTORC2↓, 1,   p70S6↓, 1,   P70S6K↓, 3,   p‑P70S6K↓, 3,   P90RSK↓, 1,   PDGFR-BB↓, 2,   p‑PDGFR-BB↓, 1,   PFKFB2↓, 1,   PI3K?, 1,   PI3K↓, 58,   PI3K↑, 4,   p‑PI3K↓, 3,   PI3K/Akt↓, 1,   PKA↓, 1,   PKA↑, 1,   PKCδ↓, 5,   PP2A↑, 1,   PTEN↑, 12,   Raf↓, 2,   c-Raf↓, 1,   RAS↓, 6,   RCC1↓, 1,   p‑S6K↓, 1,   SHP1↑, 2,   Sp1/3/4↓, 7,   Src↓, 1,   STAT↓, 2,   STAT3↓, 46,   STAT3↝, 1,   p‑STAT3↓, 9,   p‑STAT3↑, 4,   STAT4↓, 2,   STAT5↓, 2,   STAT6↓, 2,   STK11/LKB1↑, 1,   TSC2↑, 1,  

Transcription & Epigenetics(tgid=7) ⓘ

ATF3↑, 1,   ATF4↓, 1,   ATF4↑, 7,   ChrMod↝, 1,   cJun↓, 7,   cJun↑, 3,   cMyc↓, 24,   DNMT1↓, 7,   DNMT3A↓, 2,   DNMT3B↓, 1,   DNMTs↓, 7,   EZH2↓, 3,   FOXM1↓, 3,   FOXO↑, 1,   FOXO1↓, 3,   FOXO3↓, 2,   FOXO3↑, 8,   FOXO4↓, 1,   FOXO4↑, 1,   H3↑, 2,   ac‑H3↑, 3,   H3K4↓, 1,   H3K9↓, 3,   H4↑, 1,   ac‑H4↑, 3,   HATs↓, 3,   HATs↑, 1,   HDAC↓, 21,   HDAC1↓, 3,   HDAC2↓, 4,   HDAC3↓, 3,   HDAC6↓, 1,   HDAC8↓, 2,   HMTs↓, 1,   KLF2↓, 1,   KLF4↓, 1,   KLF5↓, 1,   miR-107↑, 1,   miR-124-3p↓, 1,   miR-126↑, 1,   miR-139-5p↑, 1,   miR-155↓, 1,   miR-200b↑, 1,   miR-200c↑, 1,   miR-21↓, 2,   miR-224↓, 1,   miR-25-5p↓, 1,   miR-27a-3p↓, 1,   miR-29b↓, 1,   miR-340↓, 1,   miR-34a↓, 1,   miR-34a↑, 2,   miR-375↑, 1,   miR-384↑, 1,   miR-422a↑, 1,   Myc↓, 4,   Myc↑, 1,   MYCN↑, 1,   n-MYC↓, 2,   NDRG1↑, 1,   OCT4↓, 9,   OLIG2↓, 1,   other↓, 5,   other↑, 9,   other⇅, 1,   other↝, 12,   PCAF↓, 1,   PhotoS↑, 3,   sonoS↑, 2,   SOX2↓, 5,   SOX4↓, 2,   SOX9?, 1,   SOX9↓, 1,   SUV39H↓, 3,   TCF-4↓, 1,   tumCV?, 1,   tumCV↓, 40,   tumCV↑, 2,   tumCV∅, 1,   ZBTB10↑, 1,  

Protein Folding & ER Stress(tgid=8) ⓘ

CHOP/DDIT3↑, 10,   cl‑CHOP/DDIT3↑, 1,   eIF2α↑, 3,   p‑eIF2α↑, 2,   ER Stress↑, 38,   GRP78/BiP↓, 2,   GRP78/BiP↑, 9,   GRP78/BiP↝, 1,   GRP94↑, 1,   HSP27↓, 4,   HSP70/HSPA5↓, 7,   HSP70/HSPA5↑, 4,   HSP72↑, 1,   HSP90↓, 9,   HSPs↓, 1,   HSPs↑, 1,   IRE1↑, 3,   p‑IRE1↑, 1,   PERK↑, 5,   Proteasome?, 1,   Proteasome↓, 3,   UPR↑, 10,   XBP-1↓, 1,   XBP-1↝, 1,  

Autophagy & Lysosomes(tgid=9) ⓘ

ATG3↑, 1,   ATG5↑, 2,   ATG7↑, 2,   autoF↓, 1,   Beclin-1/ATG6↓, 1,   Beclin-1/ATG6↑, 9,   p‑Beclin-1/ATG6↑, 1,   CTSB↓, 1,   CTSD↓, 1,   CTSL↑, 1,   LAMP2↑, 1,   LC3‑Ⅱ/LC3‑Ⅰ↑, 1,   LC3B↑, 2,   LC3II↓, 1,   LC3II↑, 10,   LC3s↓, 1,   lysosome↓, 1,   MitoP↑, 1,   p62↓, 5,   p62↑, 6,   PARK2↑, 1,   SESN2↑, 1,   TumAuto↓, 1,   TumAuto↑, 39,   TumAuto⇅, 2,  

DNA Damage & Repair(tgid=10) ⓘ

APE1/APEX1↓, 1,   BRCA1↓, 1,   DNA-PK↑, 2,   DNAdam↑, 46,   DNArepair↓, 3,   DNArepair↑, 1,   ERCC1↓, 1,   ERCC3↑, 1,   m-FAM72A↓, 1,   hTERT/TERT↓, 10,   MGMT↓, 1,   NKX3.1↓, 1,   p16↑, 1,   P53↓, 2,   P53↑, 43,   p‑P53↓, 1,   p‑P53↑, 3,   PARP↑, 10,   p‑PARP↑, 1,   cl‑PARP↓, 1,   cl‑PARP↑, 39,   cl‑PARP↝, 1,   PARP1↑, 1,   cl‑PARP1↑, 3,   PCNA↓, 14,   POLD1↓, 1,   SIRT6↓, 1,   Telomerase↓, 7,   TOP1↓, 5,   TOP2↓, 2,   TOP2↑, 1,   TP53↓, 2,   TP53↑, 3,   XRCC1↓, 1,   γH2AX↑, 5,  

Cell Cycle & Senescence(tgid=11) ⓘ

AURKB↓, 1,   CC(CDKs/cyclins)↓, 2,   CDK1↓, 10,   CDK2↓, 23,   CDK4↓, 30,   CDK4↑, 3,   CDK6↓, 9,   CDK6↑, 4,   CDKN1C/p57↑, 1,   CHK1↓, 2,   p‑CHK1↑, 1,   Chk2↓, 1,   ChrCon↑, 1,   Cyc↓, 2,   cycA1/CCNA1↓, 5,   CycB/CCNB1↓, 13,   cycD1/CCND1↓, 45,   CycD3↓, 3,   cycE/CCNE↓, 16,   cycE1↓, 1,   E2Fs↓, 2,   GADD45A↑, 1,   Ki-67↓, 26,   Ki-67↑, 1,   mitA↑, 2,   P21?, 2,   P21↓, 4,   P21↑, 28,   p27/CDKN1B↓, 2,   p27/CDKN1B↑, 10,   pRB↓, 1,   p‑pRB↓, 2,   RB1↑, 1,   p‑RB1↓, 3,   RRM2↓, 1,   Securin↓, 1,   TubPol↓, 1,   TumCCA?, 1,   TumCCA↓, 4,   TumCCA↑, 111,   WEE1↑, 1,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

ALDH↓, 5,   ALDH1A1↓, 1,   CD133↓, 4,   CD133↑, 1,   CD24↓, 1,   cFos↓, 7,   cMYB↓, 2,   CSCs?, 1,   CSCs↓, 41,   CSCsMark↓, 1,   Diff↓, 3,   Diff↑, 6,   FGF↓, 1,   Gli↓, 1,   Gli1↓, 6,   HH↓, 8,   HMGCR↓, 1,   HMGCR↑, 1,   HMGCR⇅, 1,   IGF-1?, 1,   IGF-1↓, 7,   IGFBP1↑, 2,   IGFBP3↑, 1,   Ki-67↓, 26,   Ki-67↑, 1,   Let-7↑, 2,   LRP6↓, 1,   mTORC1↓, 5,   p‑mTORC1↓, 1,   Nanog↓, 11,   Nestin↓, 3,   NOTCH↓, 6,   NOTCH↑, 2,   NOTCH1↓, 8,   NOTCH1↑, 4,   NOTCH2↑, 1,   NOTCH3↓, 3,   OGFr↑, 1,   p300↓, 1,   PTCH1↓, 3,   PTCH2↓, 2,   SAL↑, 1,   Shh↓, 4,   Smo↓, 2,   TumCG?, 1,   TumCG↓, 83,   TumCG↑, 3,   TumCP?, 1,   TumCP↓, 82,   TumCP↑, 2,   tyrosinase↓, 1,   Wnt↓, 23,   Wnt↑, 2,   Wnt/(β-catenin)↓, 1,  

Migration(tgid=13) ⓘ

annexin II↓, 1,   AntiAg?, 1,   AntiAg↓, 1,   AntiAg↑, 2,   AP-1↓, 7,   AXL↓, 1,   BACH1↓, 1,   Ca+2↓, 2,   Ca+2↑, 16,   CAFs/TAFs↓, 1,   cal2↑, 1,   Cal9↑, 1,   CD11b↑, 2,   Cofilin↓, 1,   COL1↓, 2,   E-cadherin↓, 4,   E-cadherin↑, 31,   EMT↓, 54,   EMT↑, 2,   FAK↓, 5,   p‑FAK↓, 2,   fascin↓, 2,   Fibronectin↓, 7,   GLI2↓, 1,   ITGB1↓, 1,   ITGB3↓, 1,   ITGB4↓, 1,   KAI1/CD82↑, 1,   KRAS↓, 2,   L-sel↑, 1,   LAMs↓, 2,   MALAT1↓, 3,   MET↓, 1,   MMP-10↓, 1,   MMP1↓, 4,   MMP13↓, 1,   MMP15↓, 1,   MMP16↓, 1,   MMP2↓, 48,   MMP2↑, 1,   MMP3↓, 2,   MMP7↓, 6,   MMP9↓, 57,   MMP9↑, 2,   MMPs↓, 20,   MUC1↑, 1,   MUC4↓, 1,   N-cadherin↓, 18,   PAK1↓, 1,   PDGF↓, 2,   RECK↑, 1,   Rho↓, 1,   ROCK1↓, 3,   Slug↓, 10,   Smad1↓, 2,   SMAD2↓, 1,   SMAD3↓, 1,   Snail?, 1,   Snail↓, 15,   STAC2↓, 1,   T-cadherin↓, 1,   TET1↑, 4,   TGF-β↓, 12,   TGF-β1↓, 1,   TIMP1↓, 1,   TIMP1↑, 4,   TIMP2↓, 2,   TIMP2↑, 4,   pol-TregCell↓, 1,   TRIB3↑, 1,   TSP-1↑, 4,   TumCA↓, 2,   TumCI↓, 62,   TumCMig↓, 51,   TumCMig↑, 1,   TumMeta?, 1,   TumMeta↓, 44,   TumMeta↑, 3,   Twist↓, 8,   uPA↓, 9,   uPAR↓, 2,   Vim?, 1,   Vim↓, 22,   Zeb1↓, 12,   Zeb1↑, 1,   ZEB2↓, 2,   α-SMA↓, 1,   α-tubulin↓, 1,   β-catenin/ZEB1↓, 30,   β-catenin/ZEB1↑, 1,  

Angiogenesis & Vasculature(tgid=14) ⓘ

angioG↓, 69,   angioG↑, 2,   CD31/PECAM-1↓, 1,   ECM/TCF↓, 1,   eNOS↓, 2,   eNOS↑, 1,   HIF-1↓, 6,   Hif1a↓, 40,   Hif1a↑, 1,   Hypoxia↓, 2,   NO↓, 4,   NO↑, 3,   VCAM-1↓, 3,   VEGF↓, 69,   VEGFR1↓, 3,   VEGFR2/KDR/Flk1↓, 10,  

Barriers & Transport(tgid=15) ⓘ

BBB↑, 5,   BBB∅, 1,   CellMemb↑, 1,   CLDN1↓, 3,   CLDN2↓, 1,   CLDN2↑, 1,   CLDN7↑, 1,   EPR↓, 1,   EPR↑, 3,   GLUT1↓, 7,   GLUT1↑, 1,   GLUT2↓, 1,   GLUT3↑, 1,   GLUT4↓, 1,   MMP?, 1,   MMP↓, 62,   MMP↑, 4,   MMP↝, 1,   MPT↑, 4,   SMCT1∅, 1,   TRPM7↓, 1,   TRPV1↓, 1,   TRPV1↑, 1,   TRPV2↑, 1,   ZO-1↑, 1,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

CCR7↓, 1,   CD4+↑, 4,   CD44↓, 7,   CD47↓, 1,   CD59↑, 1,   CD8+↑, 10,   COX1↓, 1,   COX2/PTGS2↓, 55,   COX2/PTGS2↑, 3,   CXCL12↓, 2,   CXCR4↓, 10,   DCells↑, 1,   DR4↑, 5,   Eos↑, 1,   FOXP3↓, 1,   FOXP3↑, 1,   HCAR2↑, 1,   HMGB1↓, 3,   ICAM-1↓, 2,   IFN-γ↓, 3,   IFN-γ↑, 3,   IL1↓, 1,   IL10↓, 4,   IL10↑, 1,   IL12↓, 1,   IL12↑, 2,   IL1α↓, 1,   IL1β↓, 14,   IL1β↑, 1,   IL2↓, 3,   IL2↑, 4,   IL4↓, 2,   IL4↑, 2,   IL6↓, 24,   IL8↓, 6,   Imm↑, 26,   Imm↝, 3,   INF-γ↑, 1,   Inflam↓, 22,   pol-M1↑, 1,   M2 MC↓, 3,   MCP1/CCL2↓, 6,   MIP-1β↑, 1,   MIP2↓, 1,   MyD88↑, 1,   NF-kB↓, 73,   NF-kB↑, 4,   NF-kB↝, 1,   p‑NF-kB↓, 1,   NK cell↑, 10,   NLRP3↓, 2,   p65↓, 4,   ac‑p65↓, 1,   PD-1↓, 4,   PD-L1↓, 7,   PD-L1↑, 1,   PGE1↓, 1,   PGE2↓, 21,   PSA↓, 6,   PSA∅, 1,   T-Cell↑, 3,   T-Cell↝, 1,   TCF↓, 1,   TCF↑, 1,   Th1 response↑, 4,   Th17↑, 1,   Th2↑, 1,   TIM-3↑, 1,   TLR4↓, 2,   TLR4↑, 1,   TNF-α↓, 18,   TNF-α↑, 4,   TRADD↑, 1,   Treg lymp↓, 2,  

Cellular Microenvironment(tgid=17) ⓘ

pH↓, 2,   pH↑, 1,   pH↝, 1,   e-pH↑, 4,   i-pH↓, 1,  

Synaptic & Neurotransmission(tgid=18) ⓘ

5HT↓, 2,   PTN↓, 1,   SYN1↑, 1,  

Protein Aggregation(tgid=19) ⓘ

PSEN1/PS1↓, 1,   XO↓, 1,  

Hormonal & Nuclear Receptors(tgid=20) ⓘ

ADRB2↓, 1,   AR↓, 12,   COMT↓, 2,   CYP19↓, 1,   ER-α36↓, 4,   ER(estro)↓, 1,   ERα/ESR1↓, 1,   Estro↝, 1,   EstroRS/ERS↑, 1,   FGF21↓, 1,   GR↑, 1,   PPARα↓, 2,   PPARα↑, 1,   PPARγ↓, 1,   PPARγ↑, 4,   RANKL↓, 1,   SXR↓, 1,   SXR↑, 1,  

Drug Metabolism & Resistance(tgid=21) ⓘ

ABC↓, 1,   BioAv↓, 23,   BioAv↑, 37,   BioAv↝, 13,   BioEnh↑, 1,   CBR1↓, 1,   chemoR↓, 2,   ChemoSen?, 3,   ChemoSen↓, 3,   ChemoSen↑, 161,   ChemoSen⇅, 2,   CompStab↝, 1,   CYP1A1↓, 1,   CYP1A1↑, 2,   CYP1A2↓, 2,   CYP1B1↓, 1,   CYP2C9↓, 1,   CYP3A4↓, 3,   DDS↑, 1,   Dose?, 6,   Dose↓, 5,   Dose↑, 10,   Dose↝, 64,   Dose∅, 15,   eff↓, 34,   eff↑, 96,   eff↝, 7,   eff∅, 2,   GSTP1/GSTπ↓, 2,   GSTZ1↓, 1,   Half-Life↓, 8,   Half-Life↑, 4,   Half-Life↝, 7,   Half-Life∅, 1,   MDR1↓, 9,   MRP1/ABCC1↓, 1,   P-gp/ABCB1↓, 11,   P-gp/ABCB1↝, 1,   P-gp/ABCB1∅, 1,   P450↓, 2,   RadioS?, 1,   RadioS↑, 53,   selectivity?, 1,   selectivity↓, 1,   selectivity↑, 80,   selectivity↝, 1,   Synergy?, 2,   Synergy↓, 1,   Synergy↑, 524,   Synergy↝, 1,   Synergy∅, 1,   TET2↑, 2,  

Clinical Biomarkers(tgid=22) ⓘ

AFP?, 1,   AFP↓, 1,   ALAT↓, 4,   ALAT↑, 1,   ALB∅, 1,   ALP↓, 2,   AR↓, 12,   ascitic↓, 1,   AST↓, 2,   AST↑, 1,   BG↓, 3,   BloodF⇅, 1,   BRAF↓, 1,   BRCA1↓, 1,   CRP↓, 2,   CRP∅, 1,   E6↓, 2,   E7↓, 2,   EGFR↓, 23,   ERα/ESR1↓, 1,   EstroRS/ERS↑, 1,   EZH2↓, 3,   Ferritin↓, 2,   FOXM1↓, 3,   HER2/EBBR2↓, 9,   hTERT/TERT↓, 10,   IL6↓, 24,   IRes↓, 1,   KeyT↑, 1,   KRAS↓, 2,   LDH↓, 11,   p‑LDH↓, 1,   Myc↓, 4,   Myc↑, 1,   NOS2↓, 1,   PD-L1↓, 7,   PD-L1↑, 1,   Polyps↓, 1,   PSA↓, 6,   PSA∅, 1,   RBC↑, 1,   TG/TAG↓, 1,   TP53↓, 2,   TP53↑, 3,   TRIB3↑, 1,   Tumccf↓, 1,  

Functional Outcomes(tgid=23) ⓘ

AntiCan↓, 2,   AntiCan↑, 37,   AntiCan∅, 1,   antiNeop↑, 3,   AntiTum↓, 3,   AntiTum↑, 19,   cachexia↓, 1,   cardioP↑, 5,   CardioT↓, 1,   chemoP?, 1,   chemoP↑, 25,   chemoPv↑, 11,   ChemoSideEff↓, 13,   CR↑, 2,   fatigue↓, 3,   hepatoP↓, 1,   hepatoP↑, 6,   memory↑, 1,   Mucositis↓, 1,   neuroP↑, 5,   NP/CIPN↓, 3,   ORR↑, 1,   OS↑, 34,   OS∅, 1,   Pain↓, 1,   PDE4↓, 1,   PFS↓, 1,   PFS↑, 3,   PFS∅, 1,   Pin1↓, 2,   QoL↑, 9,   QoL∅, 2,   radioP↑, 9,   Remission↑, 3,   RenoP↑, 4,   Risk↓, 25,   Risk↑, 2,   Risk∅, 1,   Sleep↑, 1,   toxicity↓, 25,   toxicity↑, 3,   toxicity↝, 11,   toxicity∅, 5,   TumVol↓, 23,   TumW↓, 11,   Weight∅, 1,   Wound Healing↑, 1,  

Infection & Microbiome(tgid=24) ⓘ

Bacteria↓, 3,   GutMicro↑, 9,   Sepsis↓, 2,  

Ingredients & Constituents(tgid=25) ⓘ

Ingr?, 2,   Ingr↑, 1,   Ingr↝, 7,   Poly↑, 1,  
Total Targets: 977

Pathway results for Effect on Normal Cells:


Redox & Oxidative Stress(tgid=1) ⓘ

antiOx?, 1,   antiOx↓, 5,   antiOx↑, 78,   ARE↑, 1,   Catalase↑, 31,   Copper↓, 1,   Fenton↓, 1,   GPx↑, 23,   GPx4↑, 2,   GSH↑, 25,   GSR↑, 3,   GSSG↓, 1,   GSSG∅, 1,   GSTs↑, 9,   H2O2↓, 2,   H2O2↑, 1,   H2O2∅, 1,   HDL↑, 3,   HDL∅, 1,   HO-1?, 2,   HO-1↓, 1,   HO-1↑, 22,   Iron↓, 1,   i-Iron↓, 1,   Keap1↓, 3,   Keap1↝, 1,   lipid-P↓, 29,   MDA↓, 22,   MDA↑, 1,   MPO↓, 5,   NQO1↑, 1,   Nrf1↑, 2,   NRF2↑, 44,   Prx↑, 1,   RNS↓, 2,   ROS?, 2,   ROS↓, 84,   ROS↝, 1,   mt-ROS?, 1,   SAM-e↑, 1,   selenoP↑, 1,   SOD↑, 44,   SOD2↑, 2,   TAC↑, 8,   TBARS↓, 2,   Trx↑, 1,   Trx1↑, 1,   uricA↓, 1,   VitC↑, 1,   xCT/SLC7A11↑, 1,  

Metal & Cofactor Biology(tgid=2) ⓘ

IronCh↑, 5,   selm↑, 1,  

Mitochondria & Bioenergetics(tgid=3) ⓘ

compI↑, 1,   compII↑, 1,   compIII↑, 1,   compIV↑, 2,   DRP1/DNM1L↓, 1,   EGF↓, 1,   ETC↑, 1,   FIS1↓, 2,   Insulin↑, 1,   mtDam↓, 3,   OCR↑, 1,   PGC-1α↑, 2,   PGC-1α↝, 1,   TFAM↑, 2,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

5LO↓, 3,   ACC↓, 1,   adiP↑, 1,   ALAT↓, 10,   AMPK↓, 1,   AMPK↑, 9,   ATP↓, 1,   ATP↑, 9,   ATP↝, 1,   cytoP450↓, 1,   FABP4↓, 1,   FASN↓, 1,   glucose↓, 6,   glucose↝, 1,   GlucoseCon↑, 2,   GSK‐3β↓, 9,   p‑GSK‐3β↑, 1,   H2S↑, 1,   LDL↓, 10,   lipidLev↓, 3,   NAD↓, 1,   NAD↑, 1,   NAD↝, 1,   NADPH↓, 1,   NADPH↑, 1,   PONs↑, 1,   SCFAs↑, 1,   SIRT1↑, 8,   SREBF2⇅, 1,   SREBP1/SREBF1↑, 1,  

Cell Death(tgid=5) ⓘ

AIF↓, 2,   Apoptosis↓, 7,   BAX↓, 4,   BAX↑, 1,   Bax:Bcl2↓, 2,   Bcl-2↓, 2,   Bcl-2↑, 3,   Casp↓, 1,   Casp12↓, 1,   Casp3?, 1,   Casp3↓, 8,   Casp3↑, 1,   cl‑Casp8↑, 1,   Casp9↓, 2,   Casp9↑, 1,   Cyt‑c↓, 3,   Fas↓, 1,   FasL↓, 1,   Ferroptosis↓, 4,   GranB/GZMB↓, 1,   iNOS↓, 12,   p38↓, 1,  

Kinase & Signal Transduction(tgid=6) ⓘ

Akt↓, 5,   Akt↑, 5,   AKT1↓, 1,   Akt2↓, 1,   AMPKα↑, 1,   CREB↑, 2,   p‑CREB↑, 2,   EGFR↓, 1,   ERK↓, 3,   ERK↑, 2,   IKKα↓, 1,   JNK↓, 2,   p‑JNK↓, 1,   MAPK↓, 7,   MAPK↑, 2,   mTOR↓, 3,   mTOR↑, 2,   PI3K↓, 5,   PI3K↑, 2,   PKCδ?, 1,   PKCδ↓, 3,   PKCδ↑, 2,   PTEN↓, 1,   PTEN↑, 1,   RAS↓, 1,   STAT↓, 1,   STAT3↓, 1,  

Transcription & Epigenetics(tgid=7) ⓘ

AntiThr↑, 3,   ATF4↓, 2,   p‑cMyc↑, 1,   HDAC↓, 1,   HDAC↑, 1,   other↓, 3,   other↑, 14,   other↝, 14,   other?, 1,   other∅, 1,  

Protein Folding & ER Stress(tgid=8) ⓘ

CHOP/DDIT3↓, 2,   p‑eIF2α↓, 1,   ER Stress↓, 5,   GRP78/BiP↓, 2,   GRP78/BiP↑, 1,   UPR↑, 1,   XBP-1↓, 1,  

Autophagy & Lysosomes(tgid=9) ⓘ

Beclin-1/ATG6↓, 1,   Beclin-1/ATG6↑, 1,   LC3‑Ⅱ/LC3‑Ⅰ↓, 1,   LC3‑Ⅱ/LC3‑Ⅰ↑, 1,   LC3II↓, 1,   LC3II↑, 1,   MitoP↑, 3,   p62↓, 1,   p62↑, 2,   PARK2↑, 1,  

DNA Damage & Repair(tgid=10) ⓘ

DNAdam↓, 5,   P53↓, 1,   PARP1↓, 1,   Telomerase↓, 1,   TOP1↓, 1,  

Cell Cycle & Senescence(tgid=11) ⓘ

GADD34↓, 1,   GADD45A↑, 1,   Ki-67↓, 1,   Ki-67↑, 1,   P21↓, 1,   TumCCA↑, 1,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

p‑4E-BP1↓, 1,   BMPs↑, 1,   CEBPA↓, 1,   Choline↑, 1,   Diff↝, 1,   GH↑, 1,   IGF-1↑, 1,   IGFBP1↑, 1,   Ki-67↓, 1,   Ki-67↑, 1,   neuroG↑, 1,   TumCG∅, 1,   Wnt↑, 2,  

Migration(tgid=13) ⓘ

AntiAg↓, 2,   AntiAg↑, 8,   AP-1↓, 3,   Ca+2?, 1,   Ca+2↓, 2,   Ca+2↑, 1,   Ca+2↝, 3,   Cartilage↑, 3,   LRP1↑, 1,   MLC2/MYL9↝, 1,   MMP2↓, 1,   MMP9↓, 1,   MMPs↓, 3,   MUC1↑, 1,   serineP↓, 1,   TGF-β↓, 3,   TGF-β↑, 1,   TGF-β1↓, 1,   uPA↑, 1,   α-SMA↝, 1,   β-catenin/ZEB1↑, 2,  

Angiogenesis & Vasculature(tgid=14) ⓘ

angioG↓, 3,   angioG↑, 2,   eNOS↓, 1,   HIF-1↓, 1,   Hif1a↓, 1,   Hif1a↑, 1,   NO?, 1,   NO↓, 9,   NO↑, 1,   TXA2↓, 1,   VCAM-1↓, 6,   VEGF↑, 1,  

Barriers & Transport(tgid=15) ⓘ

BBB↓, 2,   BBB↑, 15,   BBB↝, 1,   EPR↑, 1,   GastroP↑, 2,   GLUT2↑, 1,   GLUT3↑, 1,   GLUT4↑, 2,   IBI↑, 3,   memfluid↑, 1,   MMP↑, 8,   MUC19↓, 1,   MUC2↓, 1,   OCLN↑, 1,   OCLN↝, 1,   TJ↑, 1,   TRPA1↑, 1,   TRPV3↑, 1,   VGSC↓, 1,   ZO-1↑, 1,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

CD4+↑, 1,   COX1↓, 2,   COX2/PTGS2↓, 19,   COX2/PTGS2↑, 1,   ICAM-1↓, 3,   IFN-γ↓, 3,   IFN-γ↑, 2,   IL1?, 1,   IL1↓, 3,   IL10↓, 3,   IL10↑, 4,   IL12↓, 1,   IL17↓, 3,   IL18↓, 2,   IL1β↓, 22,   IL2↓, 2,   IL33↓, 1,   IL4↓, 2,   IL4↑, 1,   IL6?, 2,   IL6↓, 35,   IL8↓, 3,   Imm↓, 1,   Imm↑, 8,   Imm↝, 1,   INF-γ↑, 1,   Inflam?, 1,   Inflam↓, 98,   Inflam↑, 2,   IRF3↓, 1,   LPS↓, 1,   pol-M2 MC↑, 1,   MCP1/CCL2↓, 2,   MCP1/CCL2↝, 1,   MyD88↓, 1,   NeuroI↓, 5,   NF-kB↓, 33,   p‑NF-kB↓, 1,   NK cell↑, 1,   NLRP3↓, 8,   NLRP3↑, 1,   PGE2↓, 9,   PSA↓, 2,   RAGE↓, 2,   TLR2↓, 2,   TLR4↓, 3,   TLR4↑, 1,   TNF-α?, 1,   TNF-α↓, 44,   TNF-α↑, 1,   VitD↑, 2,   β-HEX↓, 1,  

Cellular Microenvironment(tgid=17) ⓘ

GFAP↓, 2,   pH↝, 1,  

Synaptic & Neurotransmission(tgid=18) ⓘ

5HT↑, 3,   Ach↑, 2,   AChE↓, 11,   BChE↓, 3,   BDNF↓, 1,   BDNF↑, 12,   ChAT↑, 1,   GABA↑, 3,   MAOA↓, 3,   MAOB↓, 1,   NGF↑, 1,   PSD95↑, 1,   RELN↑, 1,   SNAP25↑, 1,   TrkB↑, 2,  

Protein Aggregation(tgid=19) ⓘ

AGEs↓, 2,   APP↓, 3,   Aβ↓, 18,   BACE/β-secretase↓, 9,   PSEN1/PS1↓, 2,   PSEN2/PS-2↓, 1,   tau↓, 8,   p‑tau↓, 9,  

Hormonal & Nuclear Receptors(tgid=20) ⓘ

CYP19↓, 1,   DHT↓, 1,   Leptin↓, 1,   PPARγ↓, 3,   PPARγ↑, 3,   p‑PPARγ↓, 1,   testos↓, 1,   testos↑, 1,   TSHR↓, 1,  

Drug Metabolism & Resistance(tgid=21) ⓘ

ABC↓, 1,   BioAv↓, 26,   BioAv↑, 47,   BioAv⇅, 2,   BioAv↝, 18,   BioEnh↑, 3,   ChemoSen↑, 2,   CompStab↑, 2,   CompStab↝, 2,   CYP3A2↓, 1,   Dose?, 1,   Dose↑, 4,   Dose↝, 31,   eff?, 1,   eff↓, 1,   eff↑, 19,   GSTA1↑, 1,   Half-Life↓, 2,   Half-Life↑, 1,   Half-Life↝, 11,   MRP1/ABCC1↓, 1,   P-gp/ABCB1↓, 1,   P450↓, 2,   selectivity↑, 2,   Synergy↑, 87,  

Clinical Biomarkers(tgid=22) ⓘ

ALAT↓, 10,   ALP↓, 2,   AST↓, 14,   BloodF↑, 3,   BMD↑, 3,   BP↓, 9,   BP↝, 2,   Calcium↑, 1,   CK/CK-MB↓, 1,   creat↓, 3,   CRP↓, 8,   EGFR↓, 1,   Hcy/homoC↝, 1,   HOMA↓, 1,   hs-CRP↓, 3,   IL6?, 2,   IL6↓, 35,   LDH↓, 3,   Mag↑, 1,   NOS2↓, 1,   PSA↓, 2,   RAGE↓, 2,   TC↓, 3,   TG/TAG↓, 2,   TMAO↓, 1,   UFR↑, 1,   UR↓, 1,   Urea↓, 2,   VitD↑, 2,  

Functional Outcomes(tgid=23) ⓘ

Analgesic↑, 2,   AntiAge↑, 5,   antiAll↑, 9,   AntiArt↑, 5,   AntiCan↑, 17,   AntiDiabetic↑, 15,   AntiMyl↑, 1,   antiPs↑, 2,   AntiTum↓, 1,   AntiTum↑, 3,   cardioP↓, 1,   cardioP↑, 35,   CardioT↓, 1,   chemoP↑, 11,   chemoPv↑, 5,   ChemoSideEff↓, 1,   cognitive↑, 31,   cognitive↝, 1,   diuretic↑, 2,   hepatoP↑, 29,   Learn↑, 3,   memory↑, 25,   Mood↑, 2,   motorD↑, 3,   neuroP↓, 1,   neuroP↑, 64,   Obesity↓, 12,   Pain↓, 5,   QoL↑, 2,   radioP↑, 8,   RenoP↑, 11,   Risk↓, 5,   Sleep↑, 6,   Strength↑, 1,   Stress↓, 2,   Stroke↓, 6,   toxicity↓, 38,   toxicity↑, 2,   toxicity⇅, 1,   toxicity↝, 11,   toxicity∅, 6,   Weight↓, 1,   Wound Healing↑, 3,  

Infection & Microbiome(tgid=24) ⓘ

AntiBio↑, 6,   AntiFungal↓, 1,   AntiFungal↑, 4,   AntiP↑, 1,   AntiViral↑, 7,   Bacteria↓, 18,   Diar↓, 3,   GutMicro↑, 21,   Sepsis↓, 1,  

Ingredients & Constituents(tgid=25) ⓘ

Ingr?, 1,   Ingr↑, 3,   Ingr↝, 9,  
Total Targets: 444

Scientific Paper Hit Count for: Synergy, Synergy
23 Curcumin
16 Vitamin C (Ascorbic Acid)
15 Sulforaphane (mainly Broccoli)
15 Melatonin
14 Quercetin
13 Metformin
13 Chrysin
12 Dichloroacetate
11 Lycopene
10 Silver-NanoParticles
10 Chemotherapy
10 EGCG (Epigallocatechin Gallate)
9 Resveratrol
9 immunotherapy
9 mebendazole
8 Artemisinin
8 Ashwagandha(Withaferin A)
8 Fisetin
7 Atorvastatin
7 Berberine
7 Phenethyl isothiocyanate
6 Radiotherapy/Radiation
6 Hyperthermia
6 Magnetic Fields
6 Apigenin (mainly Parsley)
6 Vitamin K2
6 Silymarin (Milk Thistle) silibinin
6 phytic acid, Inositol hexakisphosphate
6 Inositol
6 Bicarbonate(Sodium)
6 Thymoquinone
5 3-bromopyruvate
5 Photodynamic Therapy
5 Dipyridamole
5 Carvacrol
5 diet FMD Fasting Mimicking Diet
5 Fenbendazole
5 Formononetin
5 Flaxseed/Linseed
5 Gambogic Acid
5 Matrine
5 Phycocyanin
5 Rosmarinic acid
5 VitK3,menadione
4 Auranofin
4 Alpha-Lipoic-Acid
4 Gemcitabine (Gemzar)
4 Isothiocyanates
4 Propolis -bee glue
4 Capsaicin
4 salinomycin
4 diet Methionine-Restricted Diet
4 Dandelion Root
4 Disulfiram
4 doxorubicin
4 Hydrogen Gas
4 MCT, metronomic chemo
4 Piperlongumine
4 Urolithin
3 1,8-Cineole
3 Astaxanthin
3 beta-carotene(VitA)
3 Benzyl isothiocyanate
3 borneol
3 Caffeic acid
3 Carnosic acid
3 NTP, Non-Thermal Plasma,Cold Atmospheric Plasma
3 chaetocin
3 chitosan
3 5-fluorouracil
3 Copper and Cu NanoParticles
3 Piperine
3 Chlorella (Chlorella vulgaris)
3 Spirulina(Arthrospira/Limnospira)
3 Diindolylmethane
3 Mistletoe/Viscum album Extracts
3 Emodin
3 Eugenol
3 Genistein (soy isoflavone)
3 Honokiol
3 Ivermectin
3 Juglone
3 Kaempferol
3 Luteolin
3 methylseleninic acid
3 Terpinen-4-ol / Tea Tree Oil
3 Selenium NanoParticles
3 Zyflamend
2 2-DeoxyGlucose
2 cetuximab
2 Vitamin B12
2 Folic Acid, Vit B9
2 chemodynamic therapy
2 SonoDynamic Therapy UltraSound
2 Trichostatin A
2 Allicin (mainly Garlic)
2 Andrographis
2 isoquercitrin
2 Aspirin
2 Baicalein
2 Biochanin A
2 Betulinic acid
2 Lutein
2 Zeaxanthin
2 Allyl isothiocyanate
2 hydroxychloroquine
2 Thymol-Thymus vulgaris
2 Sorafenib (brand name Nexavar)
2 Camu camu
2 Chlorogenic acid
2 Trastuzumab
2 Citric Acid
2 Coenzyme Q10
2 Ellagic acid
2 Bortezomib
2 Docosahexaenoic Acid
2 Oxygen, Hyperbaric
2 Indole-3-carbinol
2 Vitamin A, Retinoic Acid
2 erastin
2 Exercise
2 Ferulic acid
2 ferumoxytol
2 Fucoidan
2 Gallic acid
2 Cisplatin
2 Gamma-aminobutyric acid
2 Ginkgetin
2 Gossypol/AT-101
2 HydroxyCitric Acid
2 Spermidine
2 L-Theanine
2 Lecithin
2 Mung Bean Sprouts
2 Methyl Jasmonate
2 Magnetic Field Rotating
2 magnetic nanoparticles
2 Lemon Balm/Melissa officinalis
2 Morin
2 Methylsulfonylmethane
2 Niclosamide (Niclocide)
2 Phenylbutyrate
2 Shikonin
2 Selenite (Sodium)
2 Vitamin D3
1 Serotonin, 5-hydroxytryptamine
1 dietMediterranean
1 EMF
1 Phyllanthus emblica/Emblica officinalis/Amla / Indian Gooseberry
1 Anti-oxidants
1 Acer okamotoanum
1 5-Aminolevulinic acid
1 almonertinib
1 D-limonene
1 Huperzine A/Huperzia serrata
1 Bufalin/Huachansu
1 Bifidobacterium
1 Boron
1 Boswellia (frankincense)
1 Butyrate
1 Cannabidiol
1 Centella asiatica / Gotu kola → asiaticoside
1 Beta‐Lapachone
1 Chlorophyllin
1 Rutin
1 Cinnamon
1 Hydroxycinnamic-acid
1 Selenium
1 Cucurbitacin
1 Vitamin B1/Thiamine
1 Dasatinib/Phyrago
1 Diclofenac
1 diet Ketogenic
1 Ormeloxifene (Centchroman)
1 Docetaxel
1 Ascorbyl Palmitate
1 Echinacea
1 Electrical Pulses
1 Beta-Caryophyllene
1 temozolomide
1 Geldanamycin
1 Radicicol/monorden
1 carboplatin
1 Flaxseed Oil
1 Arsenic trioxide
1 olaparib/LYNPARZA
1 Galloflavin
1 verapamil
1 Garcinol
1 Ginkgo biloba
1 Germanium Organic/Ge-132 / propagermanium (organogermanium)
1 Ginkgolide B
1 Gold NanoParticles
1 Calorie Restriction Mimetics
1 iodine
1 Inulin Prebiotic
1 Isorhamnetin
1 capecitabine
1 isoorientin
1 itraconazole
1 Recombinant Methioninase
1 tumor necrosis factor-related apoptosis-inducing ligand
1 lambertianic acid
1 Lapatinib
1 low dose naltrexone
1 Licorice
1 Linalool
1 Vitamin E
1 Methylene blue
1 Magnolol
1 Bevacizumab (brand Avastin)
1 gefitinib, erlotinib
1 Dordaviprone; Modeyso
1 Sulindac
1 Modified Citrus Pectin
1 irinotecan
1 MCT oil
1 methotrexate
1 Magnesium
1 Moringa oleifera
1 Zeolite
1 Mushroom Lion’s Mane, Hericium erinaceus
1 Bacopa monnieri
1 Naringin
1 Marjoram (Origanum majorana)
1 Paclitaxel/Taxol
1 topotecan
1 Propranolol
1 Phosphatidylserine
1 Psoralidin
1 Parthenolide
1 Pterostilbene
1 Sulfasalazine
1 Sesamin
1 acetaminophen
1 acetazolamide
1 statins
1 triptolide
1 Turmerones
1 Vitexin
1 Walnut
1 Zinc
1 Bicalutamide
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:%  Target#:1849  State#:%  Dir#:%
wNotes=0 sortOrder:rid,rpid

 

Home Page